Gomesin [PYA1E]

General Information


DCTPep ID  DCTPep04688

Peptide Name   Gomesin [PYA1E]

Sequence  ECRRLCYKQRCVTYCRGR

Sequence Length  18

UniProt ID  P82358 

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Cancer therapy related peptides



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available



Structure Information


PDB ID  1KFP 

Predicted Structure  Not available

(Please note that there is the predicted structure, predicted by AlphaFold)

Helicity  Not available

Linear/Cyclic  Not available

Disulfide/Other Bond  Not available

N-terminal Modification  Amidation

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C93H157N35O25S4

Absent amino acids  ADFHIMNPSW

Theoretical pI  9.58

Acidic residues  1

Basic residues  6

Polar residues  8

Molecular weight (Average)  2293.73

Molecular weight (Monoisotopic)  2292.1

Common amino acids  R

Net charge  5

Instability index (II)  65.21

Aliphatic index  37.78

Grand average of hydropathicity (GRAVY)  -1.061

Half Life 
  1 hours (mammalian reticulocytes, in vitro).
  30 min (yeast, in vivo).
  >10 hours (Escherichia coli, in vivo).

Extinction coefficients 
  Ext. coefficient 3230
  Abs 0.1% (=1 g/l) 1.408, assuming all pairs of Cys residues form cystines
  Ext. coefficient 2980
  Abs 0.1% (=1 g/l) 1.299, assuming all Cys residues are reduced

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 30068931

Title  Gomesin inhibits melanoma growth by manipulating key signaling cascades that control cell death and proliferation

Doi 10.1038/s41598-018-29826-4

Year  2018

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




CancerPPD ID  4435

DBAASP ID  10905

DCTPep is developed by Dr.Zheng's team.